The European Commission has adopted an action plan to tackle antimicrobial resistance, pledging greater support for research and innovation.
The EU must play a leading role in the fight against antimicrobial resistance, the Commission stressed in its European One Health Action Plan against AMR, which it launched on 29 June. The plan has three pillars: making the EU a best-practice region; boosting R&D and innovation; and shaping global action.
Under the R&D pillar, the Commission said that greater efforts are needed to understand how resistance to antimicrobial treatments emerges and spreads among disease-causing organisms. It said it would support research into how resistant organisms proliferate in different settings, such as hospitals; how resistant organisms are transmitted between animals and humans; and the development of tools for detecting resistant organisms.